[
    {
      "id": "1",
      "title": "Novel treatment approaches in metastatic cancer",
      "authors": ["Kopetz S", "Grothey A", "Yaeger R"],
      "journal": "New England journal of Medicine",
      "year": 2023,
      "url": "https://pubmed.ncbi.nlm.nih.gov/article1",
      "abstract": "The BRAF V600E mutation occurs in 8 to 12% of patients with metastatic colorectal cancer and is associated with poor prognosis...",
      "source": "PubMed",
      "relevanceScore": 0.92
    },
    {
      "id": "2",
      "title": "Targeted therapy advancements in solid tumors",
      "authors": ["Van Cutsem E", "Huijberts S", "Grothey A"],
      "journal": "journal of Clinical Oncology",
      "year": 2022,
      "url": "https://pubmed.ncbi.nlm.nih.gov/article2",
      "abstract": "BRAF V600E-mutated metastatic colorectal cancer has a poor prognosis with limited treatment options...",
      "source": "Taylor & Francis",
      "relevanceScore": 0.89
    },
    {
      "id": "3",
      "title": "Molecular Profiling and Targeted Therapy in BRAF-Mutant Colorectal Cancer",
      "authors": ["Parseghian CM", "Napolitano S", "Loree JM"],
      "journal": "Clinical Cancer Research",
      "year": 2022,
      "url": "https://pubmed.ncbi.nlm.nih.gov/article3",
      "abstract": "Colorectal cancer (CRC) with BRAF V600E mutation represents a distinct molecular subtype with poor prognosis...",
      "source": "Science Direct",
      "relevanceScore": 0.87
    },
    {
      "id": "4",
      "title": "BEACON CRC Study: A Phase 3 Trial of Encorafenib and Cetuximab With or Without Binimetinib",
      "authors": ["Kopetz S", "Grothey A", "Van Cutsem E"],
      "journal": "Lancet Oncology",
      "year": 2021,
      "url": "https://pubmed.ncbi.nlm.nih.gov/article4",
      "abstract": "The triplet combination of encorafenib, binimetinib, and cetuximab showed promising efficacy in patients with BRAF V600E-mutated metastatic colorectal cancer...",
      "source": "PubMed",
      "relevanceScore": 0.85
    },
    {
      "id": "5",
      "title": "Clinical Outcome of Patients with BRAF V600E Mutation in Colorectal Cancer",
      "authors": ["Loupakis F", "Cremolini C", "Masi G"],
      "journal": "British journal of Cancer",
      "year": 2022,
      "url": "https://pubmed.ncbi.nlm.nih.gov/article5",
      "abstract": "BRAF V600E mutation is associated with distinctive clinicopathological features and poor prognosis in metastatic colorectal cancer...",
      "source": "Science Direct",
      "relevanceScore": 0.82
    }
  ]